The Technology Innovation Institute (TII) in Abu Dhabi has launched a Biofoundry to advance R&D in synthetic biology, focusing on genetic engineering, metabolic engineering, and bioinformatics. The facility features high-throughput robotic systems, next-generation sequencing, and advanced computational tools. TII's Biofoundry is now part of the Global Biofoundry Alliance (GBA) to foster partnerships and address shared challenges. Why it matters: This initiative positions the UAE as a key player in synthetic biology, with potential breakthroughs across healthcare, agriculture, and environmental sustainability.
The AI4Bio Workshop at MBZUAI explored the intersection of AI and biology, focusing on AI-driven virtual organisms and foundation models. Eric Xing presented his vision of using AI to simulate biological activities, offering a safer alternative to physical experiments. Researchers like Le Song and Jen Philippe Vert are developing foundation models for biological systems, enhancing drug discovery and bioengineering. Why it matters: This signals the growing importance of AI in advancing biological research and healthcare innovation within the UAE and globally.
KAUST has established the KAUST Quantum Foundry to strengthen Saudi Arabia’s ability to fabricate commercial quantum hardware. It will provide shared access to KAUST quantum cleanrooms, supporting device prototyping and process development. The Foundry will focus on process standardization and the development of Process Design Kits (PDKs) to enable researchers to design and fabricate devices. Why it matters: This initiative reinforces KAUST's role as a national hub for advanced research infrastructure and supports Saudi Arabia’s long-term innovation priorities in quantum technologies.
KAUST researchers have developed a new synthetic biology process using metabolically engineered algae to produce fragrant sesquiterpenoids, the core compounds in agarwood and other perfumes. The process, developed by the Lauersen and Szekely groups, achieved yields 25 times higher than previous methods and allows for the synthesis of 103 types of fragrant sesquiterpenoids. It also incorporates an energy-efficient nanofiltration step and operates at room temperature with minimal waste. Why it matters: This sustainable bioprocess offers a green alternative to environmentally damaging harvesting of natural resources for the $44 billion fragrance industry, with potential applications in drug development.
KAUST researchers have developed a green synthetic biology approach using engineered algae to replicate the complex fragrances of agarwood, also known as oudh. They catalogued the chemical diversity of sesquiterpenes (STPs) in 58 agarwood samples and reproduced some of the chemical complexity of agarwood STPs in algae using synthetic biology. The team used the green alga Chlamydomonas reinhardtii to produce nine distinct STP chemical products widely found in agarwood, offering a sustainable alternative to harvesting endangered trees. Why it matters: This research provides a sustainable route for producing sought-after fragrances, reducing pressure on endangered agarwood tree populations and promoting green chemistry in the region.
KAUST held its first bio-entrepreneurship ideation workshop, "Ignite Bio", for Biological and Environmental Science and Engineering students and postdoctoral fellows. Speakers from Noor Diagnostics and Discovery, Cellestia BioTech, Kyanos Biotechnology and SaudiVax shared their experiences about the startup journey. Saudi-based startups highlighted the need for services and products not currently available in the Kingdom, such as genetic diagnostic testing and local vaccine production. Why it matters: The workshop and the highlighted startups signal growing interest and opportunities for biotech innovation and entrepreneurship within Saudi Arabia.
KAUST's Laboratory of Stem Cells and Diseases, led by Assistant Professor Antonio Adamo, uses induced pluripotent stem cells (iPSCs) to model diseases like diabetes. The lab employs a reprogramming technique to revert patient fibroblasts into iPSCs, enabling the study of disease progression in vitro. Adamo's research focuses on enzymes and disregulated transcriptional/epigenetic mechanisms to understand disease onset. Why it matters: This research contributes to regenerative medicine and offers insights into metabolic diseases relevant to the GCC region.
MBZUAI researchers have developed MorphDiff, a diffusion model that predicts cell morphology from gene expression data. MorphDiff uses the transcriptome to generate realistic post-perturbation images, either from scratch or by transforming a control image. The model combines a Morphology Variational Autoencoder (MVAE) with a Latent Diffusion Model, enabling both gene-to-image generation and image-to-image transformation. Why it matters: This could significantly accelerate drug discovery and biological research by allowing scientists to preview cellular changes before conducting experiments.